EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
EQS-News: Eckert Ziegler SE
/ Key word(s): AGM/EGM
Berlin, June 26, 2024. The Annual General Meeting of Eckert Ziegler SE (ISIN DE0005659700) today resolved to split-off Pentixapharm AG from Eckert Ziegler SE and to distribute a dividend of EUR 0.05 per share for the 2023 financial year. As in the previous year, the Annual General Meeting was held as an in-person event at Eckert Ziegler SE's headquarters in Berlin. A total of 57.6% of the company's share capital was represented. The detailed voting results of the Annual General Meeting and the presentation by the Chairman of the Executive Board are published on the Eckert Ziegler SE website: About Eckert Ziegler
26.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Eckert Ziegler SE |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | +49 30 941084-138 |
Fax: | +49 30 941084-0 |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Indices: | SDAX, TecDax, |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1933989 |
End of News | EQS News Service |
|
1933989 26.06.2024 CET/CEST
Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie
Die Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie genießt klare Unterstützung: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Die Community prognostiziert für Eckert & Ziegler Strahlen- und Medizintechnik AG ein Kursziel von 95 €, was eine Steigerung von mehr als 100% gegenüber dem aktuellen Kurs von 40.36 € bedeutet.